AI-generated analysis. Always verify with the original filing.
ImmunityBio, Inc. filed an 8-K on February 18, 2026, under Items 8.01 and 9.01, attaching Exhibit 99.1, a press release dated February 18, 2026. Item 8.01 disclosures, including the exhibit, are not deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934.
Event Type
Disclosure
Voluntary
Variant
8-K
, including Exhibit 99.1 attached hereto, shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description of Exhibit 99.1** Press release dated February 18, 2026. 104 Cover Page Interactive D